Follow the 에스엘에스바이오 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에스엘에스바이오 has published 4 insider filings. The latest transaction was disclosed on 8 September 2022 (Purchase). Among the most active insiders: 이영태. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
SLS Bio 是一家在健康和制药领域运营的公司,在XKRX市场上市。它专注于开发创新的生物解决方案。